Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 60025-60026 [2017-27129]
Download as PDF
Federal Register / Vol. 82, No. 241 / Monday, December 18, 2017 / Notices
SUPPLEMENTARY INFORMATION:
daltland on DSKBBV9HB2PROD with NOTICES
I. Background
In 2003, FDA issued updated
guidance on the ‘‘replacement reagent
and instrument family policy’’ for in
vitro diagnostic (IVD) devices. The 2003
guidance described a mechanism for
manufacturers to follow when applying
an assay that was previously cleared for
use based on performance
characteristics with a specified
instrument, to an additional instrument
that was previously cleared or that is a
member of an instrument family from
which another member has been
previously cleared. Through the
approach described in the 2003
guidance, manufacturers established
sufficient control to maintain the level
of safety and effectiveness demonstrated
in the cleared device for these types of
modified devices, when evaluated
against predefined acceptance criteria
using a proper validation protocol,
without submission of a premarket
notification (510(k)).
FDA believes this policy is important
for public health as it promotes more
timely availability of a wider array of
clinical laboratory tests for patient
benefit. To ensure that its full benefits
are realized, FDA is providing
additional clarity to help manufacturers
and FDA better apply the concepts in
the guidance.
This draft guidance, when finalized,
is intended to update and provide
clarity on the Replacement Reagent and
Instrument Family Policy for
manufacturers of IVD devices and FDA
staff. It incorporates concepts and
recommendations from FDA’s guidance
entitled ‘‘Deciding When to Submit a
510(k) for a Change to an Existing
Device,’’ issued on October 25, 2017 (82
FR 49375).
II. Significance of Guidance
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the current thinking of FDA
on the Replacement Reagent and
Instrument Family Policy for In Vitro
Diagnostic Devices. It does not establish
any rights for any person and is not
binding on FDA or the public. You can
use an alternative approach if it satisfies
the requirements of the applicable
statutes and regulations. This guidance
is not subject to Executive Order 12866.
III. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by
downloading an electronic copy from
the internet. A search capability for all
VerDate Sep<11>2014
17:53 Dec 15, 2017
Jkt 244001
Center for Devices and Radiological
Health guidance documents is available
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm. This
guidance document is also available at
https://www.regulations.gov. Persons
unable to download an electronic copy
of ‘‘Replacement Reagent and
Instrument Family Policy for In Vitro
Diagnostic Devices’’ may send an email
request to CDRH-Guidance@fda.hhs.gov
to receive an electronic copy of the
document. Please use the document
number 16045 to identify the guidance
you are requesting.
IV. Paperwork Reduction Act of 1995
This draft guidance refers to
previously approved collections of
information found in FDA regulations
and guidances. These collections of
information are subject to review by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501–3520). The
collections of information in 21 CFR
part 820 are approved under OMB
control number 0910–0073; the
collections of information in 21 CFR
part 807, subpart E are approved under
OMB control number 0910–0120; the
collections of information in 21 CFR
parts 801 and 809 are approved under
OMB control number 0910–0485; the
collections of information in the
guidance document ‘‘Administrative
Procedures for CLIA [Clinical
Laboratory Improvement Amendments
of 1988] Categorization’’ are approved
under OMB control number 0910–0607;
and the collections of information for
requests for feedback on medical device
submissions in the guidance document
‘‘Requests for Feedback on Medical
Device Submissions: The PreSubmission Program and Meetings with
Food and Drug Administration Staff’’
are approved under OMB control
number 0910–0756.
Dated: December 12, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017–27132 Filed 12–15–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
60025
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34) and Implementation
Cooperative Agreement (U01).
Date: January 16, 2018.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 5601 Fishers Lane, Rockville, MD
20852, 240–669–5026, haririmf@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 12, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–27128 Filed 12–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\18DEN1.SGM
18DEN1
60026
Federal Register / Vol. 82, No. 241 / Monday, December 18, 2017 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences
Subcommittee.
Date: February 9, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minki Chatterji, Scientific
Review Officer, Scientific Review Branch,
Eunice Kennedy Shriver National Institute of
Child Health and Human Development, NIH,
DHHS, 6710B Rockledge Drive, Rm. 2121D,
Bethesda, MD 20892–7501, 301–827–5435,
minki.chatterji@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Archiving and
Documenting Child Health and Human
Development Data Sets.
Date: February 9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minki Chatterji, Scientific
Review Officer, Scientific Review Branch,
Eunice Kennedy Shriver National Institute of
Child Health and Human Development, NIH,
DHHS, 6710B Rockledge Drive, Rm. 2121D,
Bethesda, MD 20892–7501, 301–827–5435,
minki.chatterji@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: December 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–27129 Filed 12–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
The Department of Homeland Security,
Stakeholder Engagement & Cyber
Infrastructure Resilience Division
(SECIR)
National Protection and
Programs Directorate (NPPD),
Department of Homeland Security
(DHS).
ACTION: 30-Day notice and request for
comments; new information collection
request: 1670—NEW.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The DHS NPPD Office of
Cybersecurity and Communications
(CS&C), SECIR, will submit the
SUMMARY:
VerDate Sep<11>2014
17:53 Dec 15, 2017
Jkt 244001
following information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995. DHS previously
published this ICR in the Federal
Register on Tuesday, July 18, 2017 at 82
FR 32859 for a 60-day public comment
period. Ten comments from two
commenters were received by DHS. The
purpose of this notice is to allow an
additional 30 days for public comments.
DATES: Comments are encouraged and
will be accepted until January 17, 2018.
This process is conducted in accordance
with 5 CFR part 1320.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, OMB. You may send comments,
identified by the words ‘‘Department of
Homeland Security’’ and ‘‘OMB Control
Number 1670—NEW (IT Sector
Survey)’’, by:
Æ Email: dhsdeskofficer@
omb.eop.gov. Include ‘‘Department of
Homeland Security’’ and ‘‘OMB Control
Number 1670—NEW (IT Sector
Survey)’’ in the subject line of the
message.
Instructions: Comments submitted in
response to this notice may be made
available to the public through relevant
websites. For this reason, please do not
include in your comments information
of a confidential nature, such as
sensitive personal information or
proprietary information. If you send an
email comment, your email address will
be automatically captured and included
as part of the comment that is placed in
the public docket and made available on
the internet. Please note that responses
to this public comment request
containing any routine notice about the
confidentiality of the communication
will be treated as public comments that
may be made available to the public
notwithstanding the inclusion of the
routine notice.
FOR FURTHER INFORMATION CONTACT: For
specific questions related to collection
activities, please contact Reggie
McKinney at 703–705–6277 or at
reggie.mckinney@hq.dhs.gov.
SUPPLEMENTARY INFORMATION: Section
227 of the Homeland Security Act of
2002 authorizes the National
Cybersecurity and Communications
Integration Center (NCCIC) within NPPD
as a ‘‘Federal civilian interface for the
multi-directional and cross-sector
sharing of information related to . . .
cybersecurity risks.’’ 6 U.S.C. 148(c)(1).
This authority applies to Federal and
non-Federal entities, including the
private sector, small and medium
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
businesses, sectors of critical
infrastructure, and information sharing
organizations. This provision includes
the authority to receive, analyze and
disseminate information about
cybersecurity risks and incidents and to
provide guidance, assessments, incident
response support, and other technical
assistance upon request and codifies
NPPD’s coordinating role among Federal
and non-Federal entities. 6 U.S.C. 148.
As part of its information sharing
responsibilities with non-Federal
entities, the National Defense
Authorization Act For Fiscal Year 2017
(NDAA) amended the Homeland
Security Act to authorize the
Department to specifically focus on
small businesses. See Public Law 114–
328 (2016). Specifically, the NDAA
authorizes NPPD, through the Secretary,
to ‘‘leverage small business
development centers to provide
assistance to small business concerns by
disseminating information on cyber
threat indicators, defense measures,
cybersecurity risks, incidents, analyses,
and warnings to help small business
concerns in developing or enhancing
cybersecurity infrastructure, awareness
of cyber threat indicators, and cyber
training programs for employees.’’ See 6
U.S.C. 148(l)(1); see also 15 U.S.C.
648(a)(8)(A) (similarly authorizing DHS
‘‘and any other Federal department or
agency in coordination with the
Department of Homeland Security’’ to
‘‘leverage small business concerns by
disseminating information relating to
cybersecurity risks and other homeland
security matters to help small business
concerns in developing or enhancing
cybersecurity infrastructure, awareness
of cyber threat indicators, and cyber
training programs for employees’’).
Consistent with these authorities, E.O.
13636 directs the Department to
increase its cybersecurity information
sharing efforts with the private sector
and consult on and promote the
National Institute of Standards and
Technology (NIST) Cybersecurity
Framework. To facilitate the
Department’s promotion of the NIST
Cybersecurity Framework, the E.O.
directs the Secretary to establish a
voluntary program to support the
adoption of the Framework in
coordination with Sector Specific
Agencies, which in turn ‘‘shall
coordinate with Sector Coordinating
Councils to review the Cybersecurity
Framework and, if necessary, develop
implementation guidance or
supplemental materials to address
sector-specific risks and operating
environments.’’ E.O. 13636, 78 FR
11739 (2013).
E:\FR\FM\18DEN1.SGM
18DEN1
Agencies
[Federal Register Volume 82, Number 241 (Monday, December 18, 2017)]
[Notices]
[Pages 60025-60026]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27129]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 60026]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Population Sciences Subcommittee.
Date: February 9, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Minki Chatterji, Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, NIH, DHHS, 6710B Rockledge
Drive, Rm. 2121D, Bethesda, MD 20892-7501, 301-827-5435,
[email protected].
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Archiving and Documenting Child
Health and Human Development Data Sets.
Date: February 9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Minki Chatterji, Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, NIH, DHHS, 6710B Rockledge
Drive, Rm. 2121D, Bethesda, MD 20892-7501, 301-827-5435,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: December 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27129 Filed 12-15-17; 8:45 am]
BILLING CODE 4140-01-P